JIASHAN SDIC
JIASHAN SDIC
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-06-03 | Everest Medicines | Jiashan SDIC investment in Series C - Everest Medicines | 310 M USD |
More informations about "Jiashan SDIC"
Jiashan SDIC Investor Profile: Portfolio & Exits | PitchBook
Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Jiashan SDIC. Use the PitchBook Platform to explore the full profile.See details»
Jiashan SDIC - Investments, Portfolio & Company Exits
Jun 3, 2020 Jiashan SDIC has invested in Everest Medicines on Jun 3, 2020. This investment - Series C - Everest Medicines - was valued at $310M.See details»
Jiashan SDIC Portfolio Investments, Jiashan SDIC Funds, Jiashan …
Jun 8, 2020 Jiashan SDIC is a state-owned investment company established by Jiashan County in China. Use the CB Insights Platform to explore Jiashan SDIC's full profile.See details»
Everest Medicines Completes US$310 Million Series C Financing
The Series C-1 comprised of a US$50 million investment from the Jiashan SDIC, which was part of a broader strategic partnership with Jiashan National Economic and Technological …See details»
Series C - Everest Medicines - 2020-06-03 - Crunchbase
Jun 3, 2020 Everest Medicines raised $310000000 on 2020-06-03 in Series CSee details»
Everest Medicines Forms Strategic Partnership with Jiashan …
Under the terms of the agreement, Everest Medicines, a company established to develop, manufacture and commercialize innovative drugs in oncology, infectious diseases, cardio …See details»
Jiashan SDIC — 1 Portfolio companies, 1 Investments, Team
Is a VC investor with 1 investments and 1 portfolio startups.See details»
SDICVCLaunchesNationalScienceandTechnologyAchievementsTransformationInv ...
Jul 27, 2018 SDIC Venture Capital is a market-oriented investment company specially established by SDIC to better serve the national strategy and deepen cooperation with …See details»
Jiashan SDIC Investment Information | CipherBio
Find out which companies Jiashan SDIC is investing in, as well as the disease indication and therapeutic approach of every investment!See details»
Everest Medicines Forms Strategic Partnership with Jiashan …
Mar 17, 2020 Everest Medicines to place its China holding company and global manufacturing site in Jiashan National Economic and Technological Development Zone US $100 million …See details»
The official website of Zhong Lun Law Firm
The Series C-1 comprised of a US$50 million investment from the Jiashan SDIC, which was part of a broader strategic partnership with Jiashan National Economic and Technological …See details»
Chinese start-up Everest Medicines raises US$310 million in Series …
Jun 5, 2020 In March, Jiashan SDIC agreed to infuse US$100 million to support the company’s clinical trials and build drug manufacturing facilities in an economic zone in Zhejiang province …See details»
Hillhouse led a $310m Series C round in Everest Medicines.
Jun 5, 2020 Hillhouse Capital, a private equity firm, led a $310m Series C round in Everest Medicines, a biopharmaceutical startup. The investment round saw the participation from …See details»
Everest Medicines Forms Strategic Partnership with Jiashan …
Mar 17, 2020 Everest Medicines announced the formation of a strategic partnership with Jiashan National Economic and Technological Development Zone and Jiashan SDIC. Under the terms …See details»
Jiashan Manufacturing Site - Everest Medicines
In March 2020, Everest formed a strategic partnership with Jiashan National Economic and Technological Development Zone in Zhejiang province and Jiashan SDIC to build its global …See details»
Everest Medicines Completes US$310 Million Series C
Jun 5, 2020 The Series C-1 comprised of a US$50 million investment from the Jiashan SDIC, which was part of a broader strategic partnership with Jiashan National Economic and …See details»
Everest Medicines Limited announced that it expects to receive …
Mar 17, 2020 Everest Medicines Limited announced that it will receive $100 million in a round of funding from Jiashan SDIC on March 17, 2020.See details»
Campbells advises on Everest Medicines' US$310 million Series C ...
Jun 11, 2020 Campbells was very pleased to act as Cayman Islands counsel to Janchor Partners in a Series C financing by Everest Medicines Limited (Everest). The Series C-1 …See details»
City Cloud International Co., Ltd. announced that it has received …
Jul 6, 2021 City Cloud International Co., Ltd. announced that it has received over CNY 1,000,000,000 in series D round of funding on July 7, 2021. The transaction included …See details»